TÜRKÇE
ENGLISH
Information
| Unit | INSTITUTE OF MEDICAL SCIENCES |
| Code | FAR654 |
| Name | Practical Methods in Molecular Pharmacology II |
| Term | 2025-2026 Academic Year |
| Term | Fall and Spring |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 5 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Doktora Dersi |
| Type | Normal |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | |
| Course Instructor |
The current term course schedule has not been prepared yet.
|
Course Goal / Objective
The aim of this course is to provide the student with a general knowledge and equipment in the field of nanopharmacology.
Course Content
Nanopharmacology in cancer treatment: Signaling pathways in cancer-I, Nanopharmacology in cancer treatment: Signaling pathways in cancer-II, Nanopharmacology in cancer treatment: Signaling pathways in cancer-III, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-I, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-II, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-III, Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-I, Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-II, Regenerative nanopharmacology: Treatments of cardiac and neurological injuries-III, Nanopharmacology of Addiction: Gene therapy-I, Nanopharmacology of Addiction: Gene therapy-II, Nanopharmacology and Pharmacogenomics in Personalized Medicine-I, Nanopharmacology and Pharmacogenomics in Personalized Medicine-II, Nanopharmacology and Pharmacogenomics in Personalized Medicine-III
Course Precondition
Not required.
Resources
Scientific database
Notes
Scientific database
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Explains the importance of nanopharmacology in cancer treatment. |
| LO02 | Describes the use of nanopharmacology in cardiovascular diseases. |
| LO03 | Explain regenerative nanopharmacology and nanopharmacology of addiction. |
| LO04 | Tell nanopharmacology and pharmacogenomics in personalized medicine. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Beceriler - Bilişsel, Uygulamalı | Discusses the mechanisms of action, side effects, and toxic effects of drugs. | 3 |
| PLO02 | Beceriler - Bilişsel, Uygulamalı | Explains drug effects, drug interactions and effects on organ systems with a systematic approach | 3 |
| PLO03 | Yetkinlikler - Alana Özgü Yetkinlik | Plans, implements and finalizes a scientific project | |
| PLO04 | Bilgi - Kuramsal, Olgusal | Recognize the research areas and research techniques of pharmacology | 3 |
| PLO05 | Yetkinlikler - Alana Özgü Yetkinlik | Comparatively examines and compiles scientific articles in the field of pharmacology. | |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Prepares the experimental setup for an in vitro or in vivo pharmacological study and solves problems. | |
| PLO07 | Yetkinlikler - Alana Özgü Yetkinlik | He/she transforms the data obtained from the research project into a scientific research article. | |
| PLO08 | Yetkinlikler - Alana Özgü Yetkinlik | Evaluates drug use and its effects in society due to his/her knowledge about drugs. | |
| PLO09 | Bilgi - Kuramsal, Olgusal | Explain clinical phase studies in drug development. | |
| PLO10 | Beceriler - Bilişsel, Uygulamalı | Evaluates and interprets study data statistically. | |
| PLO11 | Beceriler - Bilişsel, Uygulamalı | contributes to public health with its awareness of rational drug use. |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 2 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 3 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 4 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 5 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 6 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 7 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 8 | Mid-Term Exam | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
|
| 9 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 10 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 11 | Nanopharmacology of Addiction: Gene therapy-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 12 | Nanopharmacology of Addiction: Gene therapy-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 13 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 14 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 15 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 16 | Term Exams | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
|
| 17 | Term Exams | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 3 | 42 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 3 | 42 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 15 | 15 |
| Final Exam | 1 | 30 | 30 |
| Total Workload (Hour) | 129 | ||
| Total Workload / 25 (h) | 5,16 | ||
| ECTS | 5 ECTS | ||